超纤维解:创伤后纤维解功能障碍的一个关键的表型异常
Kyosuke Takahashi1, Kazuma Yamakawa2, Anaar E Siletz1
1Division of Acute Care Surgery, University of Southern California, Los Angeles, California, USA.
Research and practice in thrombosis and haemostasis
|October 21, 2024
概括
由TEG LY30识别的创伤性纤维解质功能障碍表明,超纤维解质是常见的,并且与更糟糕的结果有关. 这项研究将纤维素分解表型与分子标记物和死亡风险相关联.
科学领域:
- 创伤和紧急医疗医学
- 血液学 血液学 血液学
- 临床病理学 临床病理学
背景情况:
- 创伤性纤维解质功能障碍被分为三个表型:纤维解质关闭,生理纤维解质和超纤维解质,基于TEG LY30.
- 这些表型的分子基础和临床结果关联仍然不完全理解.
研究的目的:
- 为了研究创伤后纤维素分解表型 (通过TEG LY30识别) 与纤维素分解的血清标志物之间的相关性.
- 评估这些纤维素分解表型与死亡率和医院并发症的关联.
主要方法:
- 实用性,随机化最佳血小板和血比率试验的二次分析.
- 患者 (N=547) 被分为低LY30 (<0.8%),正常LY30 (0.81%-0.9%) 和高LY30 (≥3%) 组.
- 序列纤维解析标志物和临床结果在各组之间进行了比较.
主要成果:
- 高LY30组在抵达时表现出高的组织等离子素激活剂和等离子素-抗等离子素水平 (P < .001).
- 在低和正常的LY30组之间没有观察到标记水平的显著差异.
- 高LY30组显示24小时和30天死亡风险增加.
结论:
- 过敏纤维解质 (高LY30) 是创伤性纤维解质功能障碍的主要形式.
- 过纤维素溶解与不良临床结果显著相关,包括死亡率增加.
相关概念视频
01:16Clot Retraction and Fibrinolysis
4.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.4K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.9K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
01:24Disorders of Hemostasis
726
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
726
01:05Introduction to Hemostasis
6.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.0K
01:30Venous Thrombosis I: Introduction
2
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
2